CVA
MLAB icon

Ceredex Value Advisors’s Mesa Laboratories MLAB Stock Holding History

Ceredex Value Advisors’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-200
Closed -$54K – 141
2021
Q2 		$54K Buy
200
+75
+60% +$19K ﹤0.01% 130
2021
Q1 		$30K Hold
125
– – ﹤0.01% 126
2020
Q4 		$36K Hold
125
– – ﹤0.01% 118
2020
Q3 		$32K Hold
125
– – ﹤0.01% 114
2020
Q2 		$27K Hold
125
– – ﹤0.01% 116
2020
Q1 		$28K Hold
125
– – ﹤0.01% 117
2019
Q4 		$31K Buy
+125
New +$29.3K ﹤0.01% 154

Other funds holding MLAB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Ceredex Value Advisors's MLAB Position: Q3 2021 in Review

Ceredex Value Advisors sold out of Mesa Laboratories (MLAB) in Q3 2021, closing a stake of 200 shares — an estimated $54K sold.

Ceredex Value Advisors first reported a position in MLAB in Q4 2019 and held it in 7 quarters. The position peaked at $54K in Q2 2021. 172 funds tracked by Wall St. Rank hold MLAB as of Q3 2021.

  • Ceredex Value Advisors reported no remaining Mesa Laboratories position as of Q3 2021 after selling out during the quarter.
  • Ceredex Value Advisors sold 200 Mesa Laboratories shares in Q3 2021, an estimated $54K.
  • Ceredex Value Advisors first reported a position in Mesa Laboratories in Q4 2019 and held it in 7 quarters.
  • Ceredex Value Advisors's Mesa Laboratories position peaked at $54K in Q2 2021.
  • 172 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2021.

Based on Ceredex Value Advisors's 13F filing for Q3 2021, filed 8 Nov 2021.